Phase II Trial of Pulsed Taxol With Concurrent Thoracic Radiotherapy, & Adjuvant Chemo in Stage III NSCLC
Status:
Terminated
Trial end date:
2017-08-22
Target enrollment:
Participant gender:
Summary
This is a phase II study to evaluate the toxicity and overall survival of pulsed paclitaxel
with concurrent thoracic radiotherapy, and adjuvant gemcitabine and carboplatin in stage IIIA
and IIIB non-small cell lung cancer